Publications by authors named "Albert Job"

Claim this Profile
S
Synthetic lethality between ATR and POLA1 reveals a potential new target for individualized cancer therapy.
Hanna Elisabeth Schneider, Lisa-Maria Schmitt, Albert Job, Brigitte Lankat-Buttgereit, Thomas Gress

Neoplasia· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The POLD1 variant increases the sensitivity of colorectal cancer cells to ATR and CHK1 inhibitors.
Albert Job, Marina Tatura, Cora Schäfer, Veronika Lutz, Hanna Schneider

Sci Rep· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inactivation of PRIM1 Function Sensitizes Cancer Cells to ATR and CHK1 Inhibitors.
Albert Job, Lisa-Maria Schmitt, Lisa von Wenserski, Brigitte Lankat-Buttgereit, Thomas M Gress

Neoplasia· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A synthetic lethal screen identifies ATR-inhibition as a novel therapeutic approach for POLD1-deficient cancers.
Sandra Hocke, Yang Guo, Albert Job, Michael Orth, Andreas Ziesch

Oncotarget· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extracellular Matrix Glycoprotein-Derived Synthetic Peptides Differentially Modulate Glioma and Sarcoma Cell Migration.
Nicole Brösicke, Muhammad Sallouh, Lisa-Marie Prior, Albert Job, Ralf Weberskirch

Cell Mol Neurobiol· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis